Coronavirus disease-19 pneumonia with facial nerve palsy and olfactory disturbance

Y Homma, M Watanabe, K Inoue, T Moritaka - Internal Medicine, 2020 - jstage.jst.go.jp
The novel coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus-2, has spread worldwide from China. There are no case reports from Asia …

[HTML][HTML] Comparison of the incidence and pattern of interstitial lung disease during erlotinib and gefitinib treatment in Japanese Patients with non-small cell lung …

…, H Ueoka, H Kamei, S Umemura, T Moritaka… - Journal of Thoracic …, 2010 - Elsevier
Background Data comparing the incidence and pattern of interstitial lung disease (ILD) in
non-small cell lung cancer patients receiving treatment with gefitinib versus erlotinib, both of …

Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung …

…, T Yonei, A Bessho, T Maeda, T Moritaka… - The Cancer …, 2005 - journals.lww.com
Risk factors for the development of interstitial lung disease in patients with non-small cell
lung cancer receiving gefitinib and the prognostic factors after interstitial lung disease …

Bronchial atresia: report of a case and review of the literature

M Mori, H Kidogawa, T Moritaka, N Ueda, K Furuya… - Surgery Today, 1993 - Springer
We report herein an unusual presentation of bronchial atresia in a 28-year-old woman, in
whom hyperlucency of the ventral segment, distal to a right extrahilar mass found on a routine …

A case of pulmonary mucoepidermoid carcinoma responding to carboplatin and paclitaxel

…, T Maeda, N Nakanishi, T Moritaka… - Japanese Journal of …, 2014 - academic.oup.com
A 59-year-old man was admitted to our hospital with dyspnea and cough. A large polypoid
tumor was observed in the lower trachea and bronchoscopic polypectomy was performed …

[HTML][HTML] Benefits and adverse events among elderly patients receiving concurrent chemoradiotherapy for locally advanced non-small cell lung cancer: analysis of the …

…, T Nagata, K Watanabe, K Gemba, T Moritaka… - Journal of Thoracic …, 2011 - Elsevier
Introduction: Thoracic radiotherapy (RT) with concurrent chemotherapy may be offered to
selected elderly patients with locally advanced non-small cell lung cancer. The Okayama Lung …

A phase III randomized trial comparing vindesine and cisplatin with or without ifosfamide in patients with advanced non-small-cell lung cancer: long-term follow-up …

…, K Kiura, M Tabata, N Takigawa, Y Segawa, T Moritaka… - Lung Cancer, 2002 - Elsevier
In order to evaluate the activity and toxicity of a three-drug combination of vindesine, ifosfamide
and cisplatin (VIP) for inoperable non-small-cell lung cancer (NSCLC), we conducted a …

Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.

T Moritaka, K Kiura, H Ueoka, M Tabata… - Anticancer …, 1998 - europepmc.org
A cisplatin-resistant cell line, SBC-3/CDDP, was established from a human small-cell lung
cancer cell line, SBC-3. The SBC-3/CDDP cells were 13.1-fold more resistant to cisplatin than …

Phase I/II study of altered schedule of cisplatin and etoposide administration and concurrent accelerated hyperfractionated thoracic radiotherapy for limited-stage …

…, Y Hiraki, Y Watanabe, T Yonei, T Moritaka… - Lung Cancer, 2003 - Elsevier
To improve the efficacy of a combination of cisplatin and etoposide and concurrent
accelerated twice-daily thoracic radiotherapy against limited-stage small-cell lung cancer, we …

Sex difference in the influence of smoking status on the responsiveness to gefitinib monotherapy in adenocarcinoma of the lung: Okayama Lung Cancer Study Group …

…, H Kamei, Y Fujiwara, A Bessho, T Moritaka… - Journal of cancer …, 2009 - Springer
Background Gefitinib is effective in patients with lung adenocarcinoma. Smoking status also
affects the responsiveness to gefitinib, but it has not been fully evaluated whether a sex …